Evidence map›Paper›PMID 37867599›Full record

ArticleFrontiers in genetics2023

Identifying potential DNA methylation markers for the detection of esophageal cancer in plasma.

Bing Pei, Guodong Zhao, Zhixin Geng, Yue Wang, Menglin Wang, Xiaomei Wang, Shangmin Xiong, Minxue Zheng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Bing Pei *The Suqian Clinical College of Xuzhou Medical University, Suqian, China.
Guodong Zhao *Zhejiang University Kunshan Biotechnology Laboratory, Zhejiang University Kunshan Innovation Institute, Kunshan, China.
Zhixin GengDepartment of Clinical Laboratory, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China.
Yue WangDepartment of R&D, Suzhou VersaBio Technologies Co Ltd., Kunshan, China.
Menglin WangDepartment of Clinical Laboratory, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China.
Xiaomei WangDepartment of R&D, Suzhou VersaBio Technologies Co Ltd., Kunshan, China.
Shangmin XiongZhejiang University Kunshan Biotechnology Laboratory, Zhejiang University Kunshan Innovation Institute, Kunshan, China.
Minxue ZhengSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, China.
Nanjing Medical University · CNChinese Academy of Sciences · CNDuke Kunshan University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA methylationearly detectionesophageal cancernon-invasiveplasma

Identifiers

PMID37867599
PMCPMC10586502
OpenAlexW4387335677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.